Fierce Biotech July 22, 2022
Astellas has rolled out plans for a $70 million innovation center on the West Coast. This sets up a consolidated shop in South San Francisco to house the Japanese pharma’s operations, which is currently scattered across the region.
The biotechnology campus will be housed in a new 154,000-square-foot building, bringing together Astellas’ research, technical operations, medical and development, commercial and relevant administrative support functions, according to a Friday press release.
Astellas said the new hub will provide lab space and support future growth as it advances cell and gene therapies in rare diseases and cancer. The company has a number of these therapies working through the clinic, including candidates for X-linked myotubular myopathy, Pompe disease and myotonic...
Today's Sponsors
Today's Sponsor